Chemical M&A Retreats Further (ICIS Chemical Business August 31 – September 5, 2024)Jonathan Choi2024-09-17T14:15:04+00:00September 5th, 2024|Featured, Our Publications|
Chemical Financing Activity Mixed (ICIS Chemical Business May 31 – June 6, 2024)Jonathan Choi2024-06-20T16:34:06+00:00May 31st, 2024|Featured, Our Publications|
Chemical M&A Market Retreats (ICIS Chemical Business May 17 – May 23, 2024)Jonathan Choi2024-05-22T20:35:28+00:00May 17th, 2024|Featured, Our Publications|
Young & Partners Chemical Financing: Reflections on 2023 and Outlook (March 2024)Jonathan Choi2024-05-22T20:36:59+00:00March 26th, 2024|Featured, Our Publications|
Biopharma Industry Business Review and Outlook (Pharmaceutical Executive, March 2024)Jonathan Choi2024-03-20T17:34:33+00:00March 20th, 2024|Featured, Our Publications|
Biopharma Market Review and Outlook (Pharmaceutical Executive, October 2023)Jonathan Choi2023-10-16T14:00:23+00:00October 16th, 2023|Featured, Our Publications|
Chem Financing to Remain Challenged (ICIS Chemical Business August 18 – August 24, 2023)Jonathan Choi2023-09-18T19:55:08+00:00August 24th, 2023|Featured, Our Publications|
Chemical M&A Activity Turns Up (ICIS Chemical Business August 11 – August 17, 2023)Jonathan Choi2023-09-18T19:55:40+00:00August 11th, 2023|Featured, Our Publications|
Young & Partners Biotech Financing Review and Outlook (June 21, 2023)Jonathan Choi2023-06-26T19:39:49+00:00June 21st, 2023|Our Publications|
Young & Partners Chemical M&A Review and Outlook (June 5, 2023)Jonathan Choi2023-06-21T19:49:37+00:00June 5th, 2023|Our Publications|
